Ballicules.com

Aminophylline

PHYLLOCONTIN

What it isWater-soluble theophylline salt; acute bronchospasm.

Why this oneIt can be given intravenously when inhaled therapy is failing.

What limits itA narrow therapeutic index with levels required, and CYP1A2 makes it interaction-prone. Largely displaced by inhaled therapy.

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Acute bronchodilation (asthma/COPD)Adult, non-smokingLoading 5.7 mg/kg IV over 30 min (ideal body weight)Maintenance infusion 0.5 mg/kg/hrTitrate to serum theophylline 10–20 mcg/mL
Acute bronchodilationPeds 1–9 yrLoading 5.7 mg/kg IVInfusion 1.0 mg/kg/hrSerum theophylline 10–20 mcg/mL

Renal Undefined

Hepatic In liver dysfunction (also cor pulmonale, cardiac decompensation, or clearance-reducing drugs), keep initial infusion ≤21 mg/hr (as aminophylline) unless serum levels are monitored.

Each 1 mg/kg (IBW) of theophylline raises serum concentration ~2 mcg/mL; aminophylline = theophylline / 0.8.

Instructions

Cautions

Adverse reactions

Pregnancy Undefined

Lactation Undefined

NO BOXED WARNINGS

Principal riskA narrow therapeutic index with levels required, and CYP1A2 makes it interaction-prone

Classes and tags

Clinical profile

Direct muscarinic antagonism0 / 4

Mechanism of action: Aminophylline ballicule

Aminophylline ballicule: receptor binding, kinetics and half-life diagram

Open Aminophylline in the interactive console ↗

Memory aids: mascots and interaction avatars

Aminophylline PHYLLOCONTIN mascot mnemonic cartoon
“A mean old Feline”
intravenous
tree → related to “tree-o-phylline” (also a CYP1A2 substrate)
Aminophylline CYP1A2 substrate avatar
CYP1A2 substrate

Open Aminophylline in the interactive console ↗